Evaluating Utility Measurement From Recurrent Marker Processes in the Presence of Competing Terminal Events
竞争性终止事件下重复标记过程的效用测量评估AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要属于竞争风险与重复事件的非参数统计方法,未直接涉及所列计量经济学细分方向。
竞争性终止事件下重复标记过程的效用测量评估AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Yifei Suna* & Mei-Cheng Wangaa Department of Biostatistics, Johns Hopkins University, Baltimore, MDCONTACT Yifei Sun ysun26@jhu.edu Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205Color versions of one or more of the figures in the article can be found online at www.tandfonline.com/r/JASA.Supplementary materials for this article are available online. Please go to www.tandfonline.com/r/JASA.ABSTRACTIn follow-up studies, utility marker measurements are usually collected upon the occurrence of recurrent events until a terminal event such as death takes place. In this article, we define the recurrent marker process to characterize utility accumulation over time. For example, with medical cost and repeated hospitalizations being treated as marker and recurrent events, respectively, the recurrent marker process is the trajectory of cumulative cost, which stops to increase after death. In many applications, competing risks arise as subjects are at risk of more than one mutually exclusive terminal event, such as death from different causes, and modeling the recurrent marker process for each failure type is often of interest. However, censoring creates challenges in the methodological development, because for censored subjects, both failure type and recurrent marker process after censoring are unobserved. To circumvent this problem, we propose a nonparametric framework for the recurrent marker process with competing terminal events. In the presence of competing risks, we start with an estimator by using marker information from uncensored subjects. As a result, the estimator can be inefficient under heavy censoring. To improve efficiency, we propose a second estimator by combining the first estimator with auxiliary information from the estimate under noncompeting risks model. The large sample properties and optimality of the second estimator are established. Simulation studies and an application to the SEER-Medicare linked data are presented to illustrate the proposed methods. Supplementary materials for this article are available online.